B M Meiser
Overview
Explore the profile of B M Meiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schaefermeier P, Szymanski D, Weiss F, Fu P, Lueth T, Schmitz C, et al.
Eur Surg Res
. 2008 Nov;
42(1):49-53.
PMID: 18987474
We developed a new fabrication technique for 3-dimensional scaffolds for tissue engineering of human heart valve tissue. A human aortic homograft was scanned with an X-ray computer tomograph. The data...
2.
Gulbins H, Meiser B, Reichenspurner H, Reichart B
Heart Surg Forum
. 2003 Jan;
5(4):E28-34.
PMID: 12538127
Purpose: Adult human myocardium cannot regenerate because cardiac muscle cells do not reenter the cell cycle. Myoblasts, cardiomyocytes, and stem cell-derived cardiomyocytes have been transplanted in experimental settings to replace...
3.
Weis M, Pehlivanli S, Meiser B, von Scheidt W
J Am Coll Cardiol
. 2001 Aug;
38(3):814-8.
PMID: 11527639
Objectives: This study was designed to assess the association between 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibition, coronary endothelial function and cytokine activation in heart transplant recipients without angiographically detectable disease....
4.
Taylor D, Barr M, Meiser B, Pham S, Mentzer R, Gass A
J Heart Lung Transplant
. 2001 Jul;
20(7):734-8.
PMID: 11448799
No abstract available.
5.
Treede H, Reichenspurner H, Meiser B, Kur F, Furst H, Vogelmeier C, et al.
Transplant Proc
. 2001 Mar;
33(1-2):1620-1.
PMID: 11267444
No abstract available.
6.
Groetzner J, Meiser B, Schirmer J, Koglin J, vScheidt W, Klauss V, et al.
Transplant Proc
. 2001 Mar;
33(1-2):1461-4.
PMID: 11267373
No abstract available.
7.
Weis M, Wildhirt S, Schulze C, Pehlivanli S, Rieder G, Wolf W, et al.
J Cardiovasc Pharmacol
. 2000 Dec;
36(6):776-84.
PMID: 11117379
Immunosuppression may have an important impact on early graft coronary endothelial injury. We investigated functional and morphologic coronary alterations, myocardial expression, and cardiac release of possible mediators of allograft vasculopathy...
8.
Weis M, Wildhirt S, Schulze C, Rieder G, Wilbert-Lampen U, Wolf W, et al.
J Heart Lung Transplant
. 1999 Dec;
18(11):1071-9.
PMID: 10598730
Background: Cytokines and growth factors released as part of the immune response to alloantigenic stimuli are capable of regulating endothelin-1 expression in the allograft. Endothelin plays a significant role as...
9.
Weis M, Wildhirt S, Schulze C, Pehlivanli S, Fraunberger P, Meiser B, et al.
Transplantation
. 1999 Nov;
68(9):1263-7.
PMID: 10573061
Background: Upon exposure to cytokines, endothelial cells may undergo profound alterations of vasomotor function. In this study, we characterized the relationship between coronary epicardial and microvascular vasomotor function and expression...
10.
Kur F, Reichenspurner H, Meiser B, Welz A, Furst H, Muller C, et al.
Thorac Cardiovasc Surg
. 1999 Aug;
47(3):174-8.
PMID: 10443520
Our positive experience with tacrolimus (FK 506) in heart transplantation has led to our assessing the use of this medication as a primary immunosuppressant in lung transplantation. 62 of our...